BG
VYNT

BlackRock Group’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

BlackRock Group’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-65
Closed -$147K – 2879
2014
Q1 		$147K Buy
+65
New +$166K ﹤0.01% 2521

Other funds holding VYNT

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $233M AUM 21.98% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return

BlackRock Group's VYNT Position: Q2 2014 in Review

BlackRock Group sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2014, closing a stake of 65 shares — an estimated $147K sold.

BlackRock Group first reported a position in VYNT in Q1 2014 and held it in 1 quarter. The position peaked at $147K in Q1 2014. 34 funds tracked by Wall St. Rank hold VYNT as of Q2 2014.

  • BlackRock Group reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • BlackRock Group sold 65 Vyant Bio, Inc. Common Stock shares in Q2 2014, an estimated $147K.
  • BlackRock Group first reported a position in Vyant Bio, Inc. Common Stock in Q1 2014 and held it in 1 quarter.
  • BlackRock Group's Vyant Bio, Inc. Common Stock position peaked at $147K in Q1 2014.
  • 34 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2014.

Based on BlackRock Group's 13F filing for Q2 2014, filed 6 Aug 2014.